Johnson and Johnson 2010 Annual Report Download - page 20

Download and view the complete annual report

Please find page 20 of the 2010 Johnson and Johnson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 80

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80

Stopping
Deadly
Infections
Nearly 125 years ago,
Johnson & Johnson pioneered
ready-to-use surgical
dressings that helped keep
pathogens from infecting
wounds. Now, Advanced
Sterilization Products (ASP),
a division of Ethicon, Inc., is
pioneering the reduction of
pathogens from health care
settings with GLOSAIR™ area
disinfection products.
The World Health
Organization estimates that in
Europe, more than 4 million
patients are affected by
approximately 4.5 million
episodes of health care-
associated infections (HAIs)
each year, causing 16 million
extra days of hospital stay and
37,000 deaths. Another conse-
quence: HAIs place significant
cost pressure on hospitals.
GLOSAIR™ helps reduce the
risk of HAIs and is on course to
become a new standard of care.
Studies show that this safe and
user-friendly technology—a
hydrogen peroxide dry-mist
system—is a more effective
method of disinfecting health
care settings, following
cleaning, than sole reliance on
manual application of tradi-
tional disinfectants.
“These machines have helped
us maintain a good standard of
cleaning and manage a safe
patient environment,” says
Paul Andrews, Housekeeping
Manager, Dorset County
Hospital, England. The local
emergency hospital has used
GLOSAIR™ 400 Systems to help
reduce HAI rates. “We’ve
achieved one of the lowest
MRSA rates in the National
Health System since adding
GLOSAIR™ to our infection-
prevention practices,” says
Andrews.
Since acquiring Gloster
Europe in 2009, ASP has
leveraged its ability to take
GLOSAIR™ to more markets.
A global rollout began with
launches throughout Europe
in 2010; plans are to launch in
the U.S. in 2011.
A World
Without
Limits for
People With
Diabetes
Diabetes is a global epidemic
that’s increasing at an
alarming rate. “One of the
biggest challenges people with
diabetes face is keeping their
blood glucose levels in range,”
says Kenneth Moritsugu, M.D.,
Vice President, LifeScan, Inc.
“Better control can lead to
fewer long-term complica-
tions and ultimately can lower
health care costs.”
That’s why the Diabetes
Care franchise remains dedi-
cated to creating a world
without limits for people with
diabetes, delivering innovative
products and tools that are
easy for health care providers
to teach and give patients
more helpful information.
In 2010, LifeScan began a
global rollout of the
OneTouch® Verio™ Blood
Glucose Monitoring System.
This accurate, easy-to-use
system requires no coding and
filters out many common
interferences, reducing the
chance for error. The system
was test-marketed in the
Netherlands with patients
on insulin therapy and
launched in Australia and
Europe. Other markets
will follow in 2011.
Also in 2010, Animas
Corporation, a leader in
insulin pump systems,
partnered with the Juvenile
Diabetes Research Foundation
to develop a first-generation
partially automated glucose
management system, a
step toward the goal of
revolutionizing
treatment
of type 1 diabetes.
INFECTION PREVENTION
Paul Andrews and colleague
Carrole White use a GLOSAIR™
400 System to help reduce
health care-associated
infections at Dorset County
Hospital in England.
JOHNSON & JOHNSON 2010 ANNUAL REPORT18